Ipilimumab Biosimilar - Ultra Low Endotoxin
Product Specifications
Specifications
Detects human CTLA-4. This non-therapeutic antibody uses the same sequence as the therapeutic antibody Ipilimumab.
Product Name Alternative
Ctla4, Cytotoxic T-lymphocyte protein 4, CD152
Host
Humanized
Species Reactivity
Human
Target
CTLA-4
Purification Method
This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.
Concentration
1.0 - 5.0 mg/mL
Endotoxin
≤ 0.1 EU/mg as determined by the LAL method
Purity
>95% by SDS-PAGE and HPLC
Buffer
ICH3001-100mL ICH3002-100mL ICH3003-100mL
Storage Conditions
Stable for at least one week when stored sterile at 2-8°C. For long term storage aseptically aliquot in working volumes without diluting and store at –80°C. Avoid Repeated Freeze Thaw Cycles.
Formulation
Phosphate buffered saline (PBS) pH 7.2,with no carrier protein, potassium or preservatives added. BSA and Azide free.
Isotype Control
https://ichor.bio/product/bulk-human-igg1-isotype-control-ib1-ich2254/
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1143048-01 0.02 mg (E-Coli)
Recombinant Vaccinia virus Uncharacterized 8.4 kDa protein (B ORF F)
Ask
View Details MBS1143048-02 0.1 mg (E-Coli)
Recombinant Vaccinia virus Uncharacterized 8.4 kDa protein (B ORF F)
Ask
View Details 
MBS1143048-03 0.02 mg (Yeast)
Recombinant Vaccinia virus Uncharacterized 8.4 kDa protein (B ORF F)
Ask
View Details MBS1143048-04 0.1 mg (Yeast)
Recombinant Vaccinia virus Uncharacterized 8.4 kDa protein (B ORF F)
Ask
View Details MBS1143048-05 0.02 mg (Baculovirus)
Recombinant Vaccinia virus Uncharacterized 8.4 kDa protein (B ORF F)
Ask
View Details